A concise review of the efficacy of stereotactic radiosurgery in the management of melanoma and renal cell carcinoma brain metastases

World Journal of Surgical Oncology

Volumn 10, Issue , 2012, Pages

  Hanson, Peter W ^a,b   Elaimy, Ameer L ^a,b   Lamoreaux, Wayne T ^a,b   Demakas, John J ^a,c   Fairbanks, Robert K ^a,b   Mackay, Alexander R ^a,d   Taylor, Blake ^a,b   Cooke, Barton S ^a   Thumma, Sudheer R ^a,b   Lee, Christopher M ^a,b,e  

^a Gamma Knife of Spokane   (United States)

^b Cancer Care Northwest   (United States)

^c Spokane Brain and Spine   (United States)

^d MacKay Meyer   (United States)

^e Gamma Knife of Spokane and Cancer Care Northwest   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD BRAIN BARRIER; BRAIN METASTASIS; CLINICAL EFFECTIVENESS; HUMAN; INTERMETHOD COMPARISON; KIDNEY CARCINOMA; MEDICAL LITERATURE; MELANOMA; MINIMALLY INVASIVE SURGERY; RADIOSENSITIVITY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; STEREOTACTIC RADIOSURGERY; TREATMENT PLANNING; WHOLE BODY RADIATION;

BRAIN NEOPLASMS; CARCINOMA, RENAL CELL; CRANIAL IRRADIATION; HUMANS; KIDNEY NEOPLASMS; MELANOMA; RADIOSURGERY;

EID: 84865422064     PISSN: None     EISSN: 14777819     Source Type: Journal    
DOI: 10.1186/1477-7819-10-176     Document Type: Review

References (26)

1. Posner JB. Management of brain metastases. Rev Neurol (Paris) 1992, 148:477-487.
2. Patchell RA. The management of brain metastases. Cancer Treat Rev 2003, 29:533-540. 10.1016/S0305-7372(03)00105-1, 14585263.
3. Manon R, O'Neill A, Knisely J, Werner-Wasik M, Lazarus HM, Wagner H, Gilbert M, Mehta M. Phase II trial of radiosurgery for one to three newly diagnosed brain metastases from renal cell carcinoma, melanoma, and sarcoma: an Eastern Cooperative Oncology Group study (E 6397). J Clin Oncol 2005, 23:8870-8876. 10.1200/JCO.2005.01.8747, 16314647.
4. Elaimy AL, Mackay AR, Lamoreaux WT, Fairbanks RK, Demakas JJ, Cooke BS, Lee CM. Clinical outcomes of stereotactic radiosurgery in the treatment of patients with metastatic brain tumors. World Neurosurg 2011, 75:673-683. 10.1016/j.wneu.2010.12.006, 21704935.
5. Samlowski WE, Watson GA, Wang M, Rao G, Klimo P, Boucher K, Shrieve DC, Jensen RL. Multimodality treatment of melanoma brain metastases incorporating stereotactic radiosurgery (SRS). Cancer 2007, 109:1855-1862. 10.1002/cncr.22605, 17351953.
6. Marko NF, Angelov L, Toms SA, Suh JH, Chao ST, Vogelbaum MA, Barnett GH, Weil RJ. Stereotactic radiosurgery as single-modality treatment of incidentally identified renal cell carcinoma brain metastases. World Neurosurg 2010, 73:186-193. discussion e29, 10.1016/j.surneu.2009.02.011, 20860956.
7. Mori Y, Kondziolka D, Flickinger JC, Kirkwood JM, Agarwala S, Lunsford LD. Stereotactic radiosurgery for cerebral metastatic melanoma: factors affecting local disease control and survival. Int J Radiat Oncol Biol Phys 1998, 42:581-589. 10.1016/S0360-3016(98)00272-7, 9806518.
8. Bullard DE, Cox EB, Seigler HF. Central nervous system metastases in malignant melanoma. Neurosurgery 1981, 8:26-30. 10.1227/00006123-198101000-00006, 7207769.
9. Amer MH, Al-Sarraf M, Baker LH, Vaitkevicius VK. Malignant melanoma and central nervous system metastases: incidence, diagnosis, treatment and survival. Cancer 1978, 42:660-668. 10.1002/1097-0142(197808)42:2<660::AID-CNCR2820420237>3.0.CO;2-E, 679158.
10. Patel JK, Didolkar MS, Pickren JW, Moore RH. Metastatic pattern of malignant melanoma. A study of 216 autopsy cases. Am J Surg 1978, 135:807-810. 10.1016/0002-9610(78)90171-X, 665907.
11. Saitoh H. Distant metastasis of renal adenocarcinoma. Cancer 1981, 48:1487-1491. 10.1002/1097-0142(19810915)48:6<1487::AID-CNCR2820480635>3.0.CO;2-9, 7272969.
12. Noel G, Valery CA, Boisserie G, Cornu P, Hasboun D, Marc Simon J, Tep B, Ledu D, Delattre JY, Marsault C, Baillet F, Mazeron JJ. LINAC radiosurgery for brain metastasis of renal cell carcinoma. Urol Oncol 2004, 22:25-31. 10.1016/S1078-1439(03)00104-2, 14969800.
13. Barth A, Wanek LA, Morton DL. Prognostic factors in 1,521 melanoma patients with distant metastases. J Am Coll Surg 1995, 181:193-201.
14. Yu C, Chen JC, Apuzzo ML, O'Day S, Giannotta SL, Weber JS, Petrovich Z. Metastatic melanoma to the brain: prognostic factors after gamma knife radiosurgery. Int J Radiat Oncol Biol Phys 2002, 52:1277-1287. 10.1016/S0360-3016(01)02772-9, 11955740.
15. Lavine SD, Petrovich Z, Cohen-Gadol AA, Masri LS, Morton DL, O'Day SJ, Essner R, Zelman V, Yu C, Luxton G, Apuzzo ML. Gamma knife radiosurgery for metastatic melanoma: an analysis of survival, outcome, and complications. Neurosurgery 1999, 44:59-64. discussion 64-56, 10.1097/00006123-199901000-00031, 9894964.
16. Sampson JH, Carter JH, Friedman AH, Seigler HF. Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma. J Neurosurg 1998, 88:11-20. 10.3171/jns.1998.88.1.0011, 9420067.
17. Chen JC, Petrovich Z, O'Day S, Morton D, Essner R, Giannotta SL, Yu C, Apuzzo ML. Stereotactic radiosurgery in the treatment of metastatic disease to the brain. Neurosurgery 2000, 47:268-279. discussion 279-281, 10.1097/00006123-200008000-00003, 10942000.
18. Wronski M, Maor MH, Davis BJ, Sawaya R, Levin VA. External radiation of brain metastases from renal carcinoma: a retrospective study of 119 patients from the M. D. Anderson Cancer Center. Int J Radiat Oncol Biol Phys 1997, 37:753-759. 10.1016/S0360-3016(97)00006-0, 9128947.
19. Gay PC, Litchy WJ, Cascino TL. Brain metastasis in hypernephroma. J Neurooncol 1987, 5:51-56. 10.1007/BF00162765, 3598621.
20. Decker DA, Decker VL, Herskovic A, Cummings GD. Brain metastases in patients with renal cell carcinoma: prognosis and treatment. J Clin Oncol 1984, 2:169-173.
21. Andrews DW, Scott CB, Sperduto PW, Flanders AE, Gaspar LE, Schell MC, Werner-Wasik M, Demas W, Ryu J, Bahary JP, Souhami L, Rotman M, Mehta MP, Curran WJ. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 2004, 363:1665-1672. 10.1016/S0140-6736(04)16250-8, 15158627.
22. Clarke JW, Register S, McGregor JM, Grecula JC, Mayr NA, Wang JZ, Li K, Gupta N, Kendra KL, Olencki TE, Cavaliere R, Sarkar A, Lo SS. Stereotactic radiosurgery with or without whole brain radiotherapy for patients with a single radioresistant brain metastasis. Am J Clin Oncol 2010, 33:70-74. 10.1097/COC.0b013e31819ccc8c, 19652578.
23. Jensen RL, Shrieve AF, Samlowski W, Shrieve DC. Outcomes of patients with brain metastases from melanoma and renal cell carcinoma after primary stereotactic radiosurgery. Clin Neurosurg 2008, 55:150-159.
24. Elaimy AL, Mackay AR, Lamoreaux WT, Fairbanks RK, Demakas JJ, Cooke BS, Peressini BJ, Holbrook JT, Lee CM. Multimodality treatment of brain metastases: an institutional survival analysis of 275 patients. World J Surg Oncol 2011, 9:69. 10.1186/1477-7819-9-69, 3148547, 21729314.
25. Aoyama H, Shirato H, Tago M, Nakagawa K, Toyoda T, Hatano K, Kenjyo M, Oya N, Hirota S, Shioura H, Kunieda E, Inomata T, Hayakawa K, Katoh N, Kobashi G. Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA 2006, 295:2483-2491. 10.1001/jama.295.21.2483, 16757720.
26. DeAngelis LM, Delattre JY, Posner JB. Radiation-induced dementia in patients cured of brain metastases. Neurology 1989, 39:789-796. 10.1212/WNL.39.6.789, 2725874.